DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18794
| null |
Trazpiroben
|
1352993-39-5
|
FH87H57Q4Y
|
(3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8 triazaspiro(4.5) decan-3-yl)methyl)benzoic acid | Benzoic acid, 3-((1-cyclohexyl-4-oxo-8-(4-oxo-4-phenylbutyl)-1,3,8-triazaspiro(4.5)dec-3-yl)methyl)- | Trazpiroben
|
BDXJYAAYLZTLEK-UHFFFAOYSA-N
|
DB18795
| null |
Traxoprodil
|
134234-12-1
|
UTC046R5HM
|
(.alpha.s,.beta.s)-4-hydroxy-.alpha.-(p-hydroxyphenyl)-.beta.-methyl-4-phenyl-1-piperidineethanol | 1-piperidineethanol, 4-hydroxy-.alpha.-(4-hydroxyphenyl)-.beta.-methyl-4-phenyl-, (s-(r*,r*))-
|
QEMSVZNTSXPFJA-HNAYVOBHSA-N
|
DB18796
| null |
Tinodasertib
|
1464151-33-4
|
MND3WX2R7I
|
4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2- a]pyridin-3-yl}benzonitrile | Tinodasertib
|
FWRFPHJSGLYXTD-UHFFFAOYSA-N
|
DB18797
| null |
Tilpisertib fosmecarbil
|
2567459-64-5
|
H1W0G02O9T
| null |
FPQIBCPWXJSFOQ-ILNPBIMBSA-N
|
DB18798
| null |
Tilpisertib
|
2065153-41-3
|
A8Y5K4G762
|
3-quinolinecarbonitrile, 6-(((s)-(1-bicyclo(1.1.1)pent-1-yl-1h-1,2,3-triazol-4-yl)(1,2-dihydro-2-methyl-1-oxo-5-isoquinolinyl)methyl)amino)-8-chloro-4-((2,2-dimethylpropyl)amino)- | Tilpisertib
|
VFGSKBLZRDRHOI-ZAGPDIDGSA-N
|
DB18799
| null |
Tigulixostat
|
1287766-55-5
|
WZ0PYQ6VLU
|
1h-pyrazole-4-carboxylic acid, 1-(3-cyano-1-(1-methylethyl)-1h-indol-5-yl)- | Tigulixostat
|
JLQQRYOWGCIMMZ-UHFFFAOYSA-N
|
DB18800
| null |
Tigilanol tiglate
|
943001-56-7
|
R1ZJT87990
|
(4s,5s,6r,7s,8r,9r,10s,11r,12r,13s,14r)-12-(2e)-2-methyl-2-enoatyl-13((2s)-2-methylbutyroyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one | 12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tiglian-3-one
|
YLQZMOUMDYVSQR-FOWZUWBHSA-N
|
DB18801
| null |
Yttrium Y-90 epratuzumab tetraxetan
|
501423-25-2
|
J36232195E
|
90y-epratuzumab | Epratuzumab tetraxetan yttrium Y-90 | Yttrium (90y) epratuzumab tetraxetan | Yttrium y 90 epratuzumab tetraxetan | Yttrium Y-90 epratuzumab tetraxetan
| null |
DB18802
| null |
Tetradecylthioacetic acid
|
2921-20-2
|
7ZU5I25S2O
|
1-(carboxymethylthio)tetradecane | Acetic acid, 2-(tetradecylthio)-
|
IPBCWPPBAWQYOO-UHFFFAOYSA-N
|
DB18803
| null |
Technetium TC-99M trofolastat
|
1333204-77-5
|
W23EFJ3KDD
|
(oc-6-33)-tricarbonyl(n2-(((1s)-1,3-dicarboxypropyl)carbamoyl)-l-.gamma.-glutamyl-n6,n6-bis((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1h-imidazol-2-yl-.kappa.n3)methyl)-l-lysine-.kappa.n6)(99mtc)technetium(+) | 99mTc-MIP-1404 | Technetium tc-99m trofolastat cation
|
RQPDXUDTXCPYGU-OIOJJZKLSA-K
|
DB18804
| null |
Tepilamide fumarate
|
1208229-58-6
|
KOS9TZ09CM
|
(n,n-diethylcarbamoyl)methyl methyl (2e)-but-2-ene-1,4-dioate | 2-(diethylamino)-2-oxoethyl and methyl (2e)-but-2-enedioate | 2-butenedioic acid (2e)-, 1-(2-(diethylamino)-2-oxoethyl) 4-methyl ester
|
AKUGRXRLHCCENI-VOTSOKGWSA-N
|
DB18805
| null |
Tenofovir amibufenamide
|
1571076-26-0
|
SGK6176ZDO
|
Alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-2-methyl-, 1-methylethyl ester | Tenofovir amibufenamide
|
ORHSFGJQGPUCRR-JTJFVBHCSA-N
|
DB18806
| null |
Temuterkib
|
1951483-29-6
|
V0Q46LFE6F
|
4h-thieno(2,3-c)pyrrol-4-one, 5,6-dihydro-6,6-dimethyl-2-(2-((1-methyl-1h-pyrazol-5-yl)amino)-4-pyrimidinyl)-5-(2-(4-morpholinyl)ethyl)- | 5,6-dihydro-6,6-dimethyl-2-(2-((1-methyl-1h-pyrazol-5-yl)amino)-4-pyrimidinyl)-5-(2-(4-morpholinyl)ethyl)-4h-thieno(2,3-c)pyrrol-4-one | Temuterkib
|
JNPRPMBJODOFEC-UHFFFAOYSA-N
|
DB18807
| null |
TBAJ-876
| null | null |
3-QUINOLINEETHANOL, 6-BROMO-.ALPHA.-(2,6-DIMETHOXY-4-PYRIDINYL)-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-2-METHOXY-.BETA.-(2,3,6-TRIMETHOXY-4-PYRIDINYL)-, (.ALPHA.S,.BETA.R)-
|
HHDDKDPLFXIPBX-JOMNFKBKSA-N
|
DB18808
| null |
TAS-303
|
1449371-87-2
|
A6XE99NLS9
|
4-PIPERIDINYL .ALPHA.-PHENYL-.ALPHA.-(PROPOXY-1,1,2,2,3,3,3-D7)BENZENEACETATE
|
FMRVAGKPRZLTRG-KORWVGAPSA-N
|
DB18809
| null |
Rocatinlimab
|
2431972-52-8
|
G770V925KP
|
Anti-CD134 human monoclonal antibody (IgG1, KHK4083 dimer)
| null |
DB18810
| null |
Tarafenacin
|
385367-47-5
|
LDV98UN52Y
|
(3r)-1-azabicyclo(2.2.2)octan-3-yl (3-fluorophenyl)((3,4,5-trifluorophenyl)methyl)carbamate | Tarafenacin
|
UXZDMXYRRQJIBJ-IBGZPJMESA-N
|
DB18811
| null |
Taminadenant
|
1337962-47-6
|
84I5UEP321
|
4-pyrimidinamine, 5-bromo-2,6-di-1h-pyrazol-1-yl- | Taminadenant
|
ATFXVNUWQOXRRU-UHFFFAOYSA-N
|
DB18812
| null |
Sovesudil
|
1333400-14-8
|
C23O3R93BM
|
(1,1'-biphenyl)-3-carboxylic acid, 2'-(aminomethyl)-5'-(((3-fluoro-4-pyridinyl)amino)carbonyl)-, propyl ester | Sovesudil
|
PNWBYIFLWUCWKS-UHFFFAOYSA-N
|
DB18813
| null |
Solasodine
|
126-17-0
|
L40Y453Y96
|
(-)-solasodine | (3.beta.,22.alpha.,25r)-spirosol-5-en-3-ol | Purapuridine | Solancarpidine | Solanearpidine | Solanidine-s | Solasadine | Solasod-5-en-3.beta.-ol | Solasodin | Spirosol-5-en-3-ol, (3.beta.,22.alpha.,25r)-
|
KWVISVAMQJWJSZ-VKROHFNGSA-N
|
DB18814
| null |
SLC-391
|
1783825-18-2
|
DSP7A26K25
|
2-Pyridinamine, 3-[5-(cyclopropylmethyl)-1,3,4-oxadiazol-2-yl]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-
|
JYVSYFGHYFXYBE-UHFFFAOYSA-N
|
DB18815
| null |
SLC-0111
|
178606-66-1
|
ANM9DBL9JT
|
4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide | Benzenesulfonamide, 4-[[[(4-fluorophenyl)amino]carbonyl]amino]-
|
YJQZNWPYLCNRLP-UHFFFAOYSA-N
|
DB18816
| null |
Sivopixant
|
2414285-40-6
|
S0N1VEG94I
|
1,3,5-triazine-1(2h)-propanoic acid, 3-((4-chlorophenyl)methyl)tetrahydro-.alpha.-methyl-2,6-dioxo-4-((4-(2-pyridinyloxy)phenyl)imino)-, (.alpha.s,4e)- | Sivopixant
|
SKZQFKBIJUXXCG-INIZCTEOSA-N
|
DB18817
| null |
Simufilam
|
1224591-33-6
|
6NV440YIO0
|
1-benzyl-8-methyl-1,4,8-triazaspiro(4.5)decan-2-one | 1,4,8-triazaspiro(4.5)decan-2-one, 8-methyl-1-(phenylmethyl)- | Simufilam
|
BSQPTZYKCAULBH-UHFFFAOYSA-N
|
DB18818
| null |
Opevesostat
|
2231294-96-3
|
1Z7MAV4KQC
|
Opevesostat
|
LHVKCOBGLZGRQZ-UHFFFAOYSA-N
|
DB18819
| null |
Ompenaclid
|
353-09-3
|
UL1984YRKA
|
.beta.-guanidinopropionic acid | 3-guanidinopropionic acid | Amidino .beta.-alanine | Amidino beta-alanine | Guanidinopropionic acid | Oristar gpa
|
KMXXSJLYVJEBHI-UHFFFAOYSA-N
|
DB18820
| null |
ODM-207
|
1801503-93-4
|
BL5NEF7JDK
|
2(1H)-Quinolinone, 6-(3,5-dimethyl-4-isoxazolyl)-7-methoxy-3-methyl-1-(2-pyridinylmethyl)- | 6-(3,5-Dimethyl-4-isoxazolyl)-7-methoxy-3-methyl-1-(2-pyridinylmethyl)-2(1H)-quinolinone | BET-IN-4
|
YVGWSVHZXWFLIT-UHFFFAOYSA-N
|
DB18821
| null |
Obeldesivir
|
2647441-36-7
|
Q55KCM7PXB
|
((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate | 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D -altrononitrile 6-(2-methylpropanoate) | D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(2-methylpropanoate) | Obeldesivir
|
YIHPGVCWGSURHO-VSBTWAGUSA-N
|
DB18822
| null |
TK-112690
|
22423-26-3
|
GQZ99GWR3T
|
6h-furo(2',3':4,5)oxazolo(3,2-a)pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-, (2r,3r,3as,9ar)- | O2,2'-anhydro-5-methyluridine
|
WLLOAUCNUMYOQI-JAGXHNFQSA-N
|
DB18823
| null |
Zemirciclib
|
2057509-72-3
|
E5XSP3X68B
|
(1s,3r)-3-(acetylamino)-n-(5-chloro-4-(5,6-dihydro-5,5-dimethyl-4h-pyrrolo(1,2-b)pyrazol-3-yl)-2-pyridinyl)cyclohexanecarboxamide | Zemirciclib
|
AVIWDYSJSPOOAR-LSDHHAIUSA-N
|
DB18824
| null |
Aldumastat
|
1957278-93-1
|
EI4HZ6P03E
|
(5s)-5-cyclopropyl-5-(3-((3s)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl)-3- oxopropyl)imidazolidine-2,4-dione | (s)-5-cyclopropyl-5-(3-((s)-4-(3,5-difluorophenyl)-3methylpiperazin-1-yl)-3-oxopropyl)imidazolidine-2,4-dione | 2,4-imidazolidinedione, 5-cyclopropyl-5-(3-((3s)-4-(3,5-difluorophenyl)-3-methyl-1-piperazinyl)-3-oxopropyl)-, (5s)- | Aldumastat
|
CMLVKUWQFZQPPS-YUNKPMOVSA-N
|
DB18825
| null |
Flutafuranol F-18
|
1211333-21-9
|
785H5FQN20
|
2-(2-(18f)fluoro-6-(methylamino)pyridin-3-yl)-1-benzofuran-5-ol | 5-benzofuranol, 2-(2-(fluoro-18f)-6-(methylamino)-3-pyridinyl)- | Flutafuranol (18F) | Flutafuranol F18
|
MYNQXTDIPMCJCR-HUYCHCPVSA-N
|
DB18826
| null |
Flotegatide (18F)
|
1010702-75-6
|
Q1MCS0I4BE
|
Cyclo(l-arginylglycyl-l-.alpha.-aspartyl-d-phenylalanyl-n6-(2,6-anhydro-7-deoxy-7-((2-(4-(3-(fluoro-18f)propyl)-1h-1,2,3-triazol-1-yl)acetyl)amino)-l-glycero-l-galacto-heptonoyl)-l-lysyl) | Flotegatide (18f) | Flotegatide F-18
|
SDQRGILXNZSUMD-ABRGNQFASA-N
|
DB18827
| null |
FAPi-46 GA-68
|
2374784-98-0
|
7X34CP0VEL
|
[68Ga]Ga-FAPI-46 | Gallium Ga 68 FAPi-46 | Gallium-68-FAPi-46
|
YRZMUMGVTRNFAJ-DJJSLDLFSA-K
|
DB18828
| null |
Coco diethanolamide
|
61791-31-9
|
92005F972D
|
Alkamide 101-cg | Amidex ce surfactant | Calamide c | Cocamide dea | Cocamide diethanolamine | Cocodiethanolamide | Coconut diethanolamide | Coconut fatty acid diethanolamide | N,n-bis(hydroxyethyl)cocamine
| null |
DB18829
| null |
ABG-023
| null | null | null | null |
DB18830
| null |
RCT1100
| null | null | null | null |
DB18831
| null |
GXC-301
| null | null | null | null |
DB18832
| null |
ISM6631
| null | null | null | null |
DB18833
| null |
Vudalimab
|
2329669-72-7
|
4I9I5X3Z6N
|
Anti-PD1 / CTLA4 Bispecific Antibody XmAb20717 | Anti-pd1/ctla4 bispecific antibody xmab20717 | Immunoglobulin half-ig g1-kappa/scfv-h-ch2-ch3, anti-(homo sapiens ctla4 (cytotoxic t-lymphocyte-associated protein 4, cd152)) and anti-(homo sapienspdcd1 (programmed cell death 1, pd-1, pd1, cd279)), monoclonal antibody, bispecific | Pd-1 x ctla-4 dual checkpoint inhibitor xmab20717
| null |
DB18834
| null |
Ensitrelvir
|
2647530-73-0
|
PX665RAA3H
| null |
QMPBBNUOBOFBFS-UHFFFAOYSA-N
|
DB18835
| null |
Amlitelimab
|
2378692-15-8
|
YZ6BH6TN8P
|
Amlitelimab | Immunoglobulin g4 (235-proline,242-glutamic acid), anti-(human ox40 ligand) (human monoclonal ky1005-2d10 .gamma.4-chain), disulfide with human monoclonal ky1005-2d10 .kappa.-chain, dimer
| null |
DB18836
| null |
Ziltivekimab
|
2226654-05-1
|
AN3Y2B4SX4
|
Immunoglobulin g1 (255-tyrosine,257-threonine,259-glutamic acid), anti-(human interleukin 6) (human monoclonal 2e2.3a9.6a3 .gamma.1-chain), disulfide with human monoclonal 2e2.3a9.6a3 .kappa.-chain, dimer
| null |
DB18837
| null |
Unasnemab
|
2379805-59-9
|
XB2155292Y
|
Immunoglobulin g1, anti-(human repulsive guidance molecule rgma) (human-mus musculus clone rh116a3 .gamma.1-chain), disulfide with human-mus musculus clone rh116a3 .kappa.-chain, dimer
| null |
DB18838
| null |
Acapatamab
|
2314491-93-3
|
GW5EID3IDO
|
Mmunoglobulin scfv-scfv-scfc, anti-(homo sapiens folh1 (folate hydrolase, prostate specific membrane antigen, psma)) and anti-(homo sapiens cd3e (cd3 epsilon, leu-4)), monoclonal antibody single chain (scfv)2-scfc, bispecific
| null |
DB18839
| null |
Tidutamab
|
2148354-90-7
|
88635FW2QX
|
Anti-sstr2/cd3 monoclonal antibody xmab18087
| null |
DB18840
| null |
Allitinib
|
897383-62-9
|
CX0M5RO7CY
|
2-propenamide, n-(4-((3-chloro-4-((3-fluorophenyl)methoxy)phenyl)amino)-6-quinazolinyl)- | N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)acrylamide | N-(4-((3-chloro-4-((3-fluorophenyl)methoxy)phenyl)amino)-6-quinazolinyl)-2-propenamide
|
MVZGYPSXNDCANY-UHFFFAOYSA-N
|
DB18841
| null |
Sutetinib
|
1259519-20-4
|
538A7S75AB
|
(2e)-n-(3-cyano-7-ethoxy-4-((3-ethynylphenyl)amino)-6-quinolinyl)-4-(dimethylamino)-2-butenamide | 2-butenamide, n-(3-cyano-7-ethoxy-4-((3-ethynylphenyl)amino)-6-quinolinyl)-4-(dimethylamino)-, (2e)-
|
NAVJYTIRRMDRQK-DHZHZOJOSA-N
|
DB18842
| null |
Avizakimab
|
2229685-51-0
|
4H3BBE5WVK
|
Immunoglobulin g1 (251-tyrosine,253-threonine,255-glutamic acid), anti-(human interleukin 21) (human-mus musculus monoclonal bos161721 .gamma.1-chain), disulfide with human-mus musculus monoclonal bos161721 .kappa.-chain, dimer
| null |
DB18843
| null |
Sonelokimab
|
1414386-05-2
|
LEN0OCZ4SH
|
M-1095 (anti-interleukin (il)-17a/f single-domain antibody)
| null |
DB18844
| null |
Befotertinib
|
1835667-63-4
|
0XT2CPR891
|
2-propenamide, n-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1h-indol-3-yl)-2-pyrimidinyl)amino)phenyl)- | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1h-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide
|
USOCZVZOXKTJTI-UHFFFAOYSA-N
|
DB18845
| null |
Socazolimab
|
2305043-30-3
|
82P4S8Q3FB
|
Immunoglobulin g1, anti-(human programmed death-ligand 1) (human monoclonal zkab001 .gamma.1-chain), disulfide with human monoclonal zkab001 .lambda.-chain, dimer
| null |
DB18846
| null |
Depemokimab
|
2243274-14-6
|
D16EQP0KKH
|
Immunoglobulin g1, anti-(human interleukin 5) (human-mus musculus monoclonal gsk3511294 .gamma.1-chain), disulfide with human-mus musculus monoclonal gsk3511294 .kappa.-chain, dimer
| null |
DB18847
| null |
Deuruxolitinib
|
1513883-39-0
|
0CA0VSF91Y
|
(3r)-3-(2,2,3,3,4,4,5,5-d8)cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)propanenitrile | 1h-pyrazole-1-propanenitrile, .beta.-(cyclopentyl-2,2,3,3,4,4,5,5-d8)-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (.beta.r)- | D8-ruxolitinib
|
HFNKQEVNSGCOJV-FBXGHSCESA-N
|
DB18848
| null |
Domvanalimab
|
2368219-35-4
|
45X7OU8C4J
|
Immunoglobulin g1 (236-alanine,237-alanine,de-c-terminal-lysine), anti-(human receptor tigit)(human-mus musculus monoclonal ab154 .gamma.1-chain), disulfide with human-mus musculus monoclonal ab154 .kappa.-chain, dimer
| null |
DB18849
| null |
Sasanlimab
|
2206792-50-7
|
LZZ0IC2EWP
|
Anti-pd-1 checkpoint inhibitor pf-06801591
| null |
DB18850
| null |
Elsubrutinib
|
1643570-24-4
|
1487U1Q3IQ
|
(s)-4-(1-acryloylpiperidin-3-yl)-1h-indole-7-carboxamide | 1h-indole-7-carboxamide, 4-((3s)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)- | 4-((3s)-1-(prop-2-enoyl)-piperidin-3-yl)-1h-indole-7-carboxamide
|
UNHZLHSLZZWMNP-LLVKDONJSA-N
|
DB18851
| null |
Rosnilimab
|
2412764-40-8
|
93OKX5KD2L
|
Immunoglobulin g1, anti-(human programmed cell death protein 1) (human-mus musculus monoclonal anb030 .gamma.1-chain), disulfide with human-mus musculus monoclonal anb030 .kappa.-chain, dimer
| null |
DB18852
| null |
Nofazinlimab
|
2377845-98-0
|
42T48Q7A6O
|
Antibody cs1003 | Immunoglobulin g4 (223-proline), anti-(human programmed cell death protein 1) (human-mus musculus monoclonal cs1003 .gamma.4-chain), disulfide with human-mus musculus monoclonal cs1003 .kappa.-chain, dimer | Recombinant pd-1 mab cs1003
| null |
DB18853
| null |
Ragifilimab
|
2207590-51-8
|
O440IW9NHN
|
Anti-gitr agonistic monoclonal antibody incagn01876 | Immunoglobulin g1 (de-448-lysine), anti-(human tumor necrosis factor receptor tnfrsf18) (human-mus musculus monoclonal incagn01876.gamma.1-chain), disulfide with human-mus musculus monoclonal incagn01876 .kappa.-chain, dimer | Incagn-01876 | Incagn01876
| null |
DB18854
| null |
Etigilimab
|
2044984-83-8
|
FC1ZF28VIT
|
Immunoglobulin g1, anti-(human receptor tigit(t-cell immunoreceptor with ig and itim domains)) (humanized mouse monoclonal omp-313m32 .gamma.1-chain), disulfide with humanized mouse monoclonal omp-313m32 .kappa.-chain, dimer
| null |
DB18855
| null |
Povorcitinib
|
1637677-22-5
|
N0JWC7RO00
| null |
MSGYSFWCPOBHEV-AWEZNQCLSA-N
|
DB18856
| null |
Plutavimab
|
2529854-88-2
|
12U14K0SR5
|
Affinity matured covi-guard | Covi-amg | Covi-drops | Immunoglobulin g1 (234-alanine,235-alanine), anti-(severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor-binding domain) (human monoclonal sti-2020 .gamma.1-chain), disulfide with human monoclonal sti-2020 .kappa.-chain, dimer
| null |
DB18857
| null |
Farletuzumab ecteribulin
|
2407465-18-1
|
UVG3B5TZN3
|
Eribulin/farletuzumab antibody drug conjugate
| null |
DB18858
| null |
Fianlimab
|
2126132-98-5
|
OX5LRQ5H6K
|
Anti-lag-3 monoclonal antibody regn3767
| null |
DB18859
| null |
Finotonlimab
|
2350298-85-8
|
533Z4G2286
|
Immunoglobulin g4 (226-proline), anti-(human programmed cell death 1) (human-mus musculus monoclonal sct-i10a .gamma.4-chain), disulfide with human-mus musculus monoclonal sct-i10a .kappa.-chain, dimer
| null |
DB18860
| null |
Galegenimab
|
2403683-24-7
|
UTI65JH23L
|
Immunoglobulin igg1 fab fragment, anti-(human serine proteinase htra1) (human-mus musculus monoclonal fhtr2163 .gamma.1-chain), disulfide with human-mus musculus monoclonal fhtr2163 .kappa.-chain
| null |
DB18861
| null |
Gatipotuzumab
|
1264737-26-9
|
85V55ZLV2Z
|
Immunoglobulin g1, anti-(mucin muc1) (human-mus musculus monoclonal pankomab-gex heavy chain), disulfide with human-mus musculus monoclonal pankomab-gex light chain, dimer
| null |
DB18862
| null |
Giloralimab
|
2226292-20-0
|
W6C58X3BFH
|
Agonistic anti-cd40 monoclonal antibody abbv-927 | Anti-cd40 agonist monoclonal antibody abbv-927 | Immunoglobulin g1, anti-(human cd40 antigen) (human-mus musculus monoclonal pr-1614645 .gamma.1-chain), disulfide with human-mus musculus monoclonal pr-1614645 .kappa.-chain, dimer
| null |
DB18863
| null |
Ginisortamab
|
2390147-17-6
|
6808SG2XRK
|
Immunoglobulin g4 (232-proline), anti-(human gremlin 1) (human monoclonal ucb6114 .gamma.4-chain), disulfide with human monoclonal ucb6114 .kappa.-chain, dimer
| null |
DB18864
| null |
Litifilimab
|
2407378-48-5
|
V27E9V3K7G
|
Immunoglobulin g1, anti-(human blood dendritic cell antigen 2) (human-mus musculus monoclonal biib059 .gamma.1-chain), disulfide with human-mus musculus monoclonal biib059 .kappa.-chain, dimer
| null |
DB18865
| null |
Naporafenib
|
1800398-38-2
|
15JL80DG6H
|
4-pyridinecarboxamide, n-(3-(2-(2-hydroxyethoxy)-6-(4-morpholinyl)-4-pyridinyl)-4-methylphenyl)-2-(trifluoromethyl)-)- | N-(3-(2-(hydroxyethoxy)-6-(morpholin-4-yl) pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)pyridine-4-carboxamide | Pan-raf inhibitor lxh254
|
UEPXBTCUIIGYCY-UHFFFAOYSA-N
|
DB18866
| null |
Nemtabrutinib
|
2095393-15-8
|
JTZ51LIXN4
|
(2-chloro-4-phenoxyphenyl)(4-(((3r,6s)-6-(hydroxymethyl)tetrahydro-2h-pyran-3-yl)amino)-7h-pyrrolo(2,3-d)pyrimidin-5-yl)methanone | 1,5-Anhydro-2-[[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3,4-trideoxy-D-erythro-hexitol | D-erythro-hexitol, 1,5-anhydro-2-((5-(2-chloro-4-phenoxybenzoyl)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)-2,3,4-trideoxy-
|
JSFCZQSJQXFJDS-QAPCUYQASA-N
|
DB18867
| null |
Zinlirvimab
|
2417213-75-1
|
L98LJF15I9
|
Anti-hiv-1 human monoclonal antibody targeting v3 glycan supersite on the hiv-1 envelope protein (10-1074)
| null |
DB18868
| null |
Zeluvalimab
|
2315361-37-4
|
DX474PAV6P
|
Anti-pd-1 monoclonal antibody amg 404 | Immunoglobulin g1 (295-cysteine,300-glycine,305-cysteine), anti-(human programmed cell death 1) (human monoclonal 20c1.009 mab .gamma.1-chain), disulfide with human monoclonal 20c1.009 mab .kappa.-chain, dimer | Zeluvalimab (immunoglobulin g1-kappa, anti-(homo sapienspdcd1 (programmed cell death 1, pd-1, pd1, cd279)), monoclonal antibody)
| null |
DB18869
| null |
Xeligekimab
|
2382921-73-3
|
MC5WXU879E
|
Immunoglobulin g4 (235-proline), anti-(human interleukin 17a) (human monoclonal gr1501 .gamma.4-chain), disulfide with human monoclonal gr1501 .kappa.-chain, dimer
| null |
DB18870
| null |
Netakimab
|
1796570-08-5
|
D3IAG45DAK
|
Immunoglobulin g1, anti-(human interleukin 17) (human-lama glama monoclonal heavy chain), disulfide with human monoclonal light chain, dimer
| null |
DB18871
| null |
Vobramitamab duocarmazine
|
2490556-51-7
|
2ZK3D69DQJ
|
Anti-b7h3 antibody-drug conjugate mgc018
| null |
DB18872
| null |
Vibecotamab
|
2138442-13-2
|
JD56EJA59S
|
Anti-cd123 x anti-cd3 bispecific antibody xmab14045
| null |
DB18873
| null |
Pacmilimab
|
2145091-51-4
|
ZXP96ZI2RA
|
Cx-072 probody | IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH-LIGAND 1) (HUMAN MONOCLONAL CX-072 .GAMMA.4-CHAIN), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING) FUSION PROTEIN WITH HUMAN MONOCLONAL C | Protease-activated anti-pd-l1 antibody prodrug cx-072
| null |
DB18874
| null |
Peresolimab
|
2411580-63-5
|
DI4N99Q6KK
|
Immunoglobulin g1, anti-(human programmed cell death protein 1) (human monoclonal ly3462817 .gamma.1-chain), disulfide with human monoclonal ly3462817 .kappa.-chain, dimer
| null |
DB18875
| null |
Ubamatamab
|
2305629-50-7
|
6BUL1G4D60
|
Anti-muc16/cd3 bite antibody regn4018 | Bispecific t-cell engager antibody regn4018 | Muc16xcd3 bispecific t-cell engager regn4018
| null |
DB18876
| null |
Camoteskimab
|
2492472-82-7
|
ONX021SC9O
|
Immunoglobulin g1 (242-phenylalanine,243-glutamic acid,339-serine), anti-(human interleukin 18) (human monoclonal cerc-007 .gamma.1-chain), disulfide with human monoclonal cerc-007 .kappa.-chain, dimer
| null |
DB18877
| null |
Clesrovimab
|
2429913-18-6
|
VJO29R4CP9
|
Immunoglobulin g1 (262-tyrosine,264-threonine,266-glutamic acid), anti-(human respiratory syncytial virus f protein) (human monoclonal rb1 .gamma.1-chain), disulfide with human monoclonal rb1 .kappa.-chain, dimer
| null |
DB18878
| null |
Divozilimab
|
2254061-60-2
|
13ZEQ1M5ML
|
Immunoglobulin g1, anti-(human cd20 antigen) (human-mus musculus monoclonal bcd-132 .gamma.1-chain), disulfide with human-mus musculus monoclonal bcd-132 .kappa.-chain, dimer
| null |
DB18879
| null |
Alintegimod
|
1378535-08-0
|
NX38VST3GU
|
Alintegimod
|
PSBCCRKKPBQYJK-UHFFFAOYSA-N
|
DB18880
| null |
Allisartan isoproxil
|
947331-05-7
|
DI4662MK4N
|
1H-IMIDAZOLE-5-CARBOXYLIC ACID, 2-BUTYL-4-CHLORO-1-((2'-(2H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, (((1-METHYLETHOXY)CARBONYL)OXY)METHYL ESTER
|
XMHJQQAKXRUCHI-UHFFFAOYSA-N
|
DB18881
| null |
Anitocabtagene autoleucel
| null | null |
anito-cel | Anitocabtagene autoleucel
| null |
DB18882
| null |
Avenciguat
|
1579514-06-9
|
ZA7KTB4PSP
|
Avenciguat
|
KWNFFNFBUMFTHK-UHFFFAOYSA-N
|
DB18883
| null |
Benapenem
|
1312953-83-5
|
RE7F9LDG3H
| null |
JNSMRGMLNPEWLR-PDCLSYJBSA-N
|
DB18884
| null |
Brogidirsen
|
2409088-11-3
|
4KM8P975UM
|
Brogidirsen | NS 089/NCNP 02 | NS089/NCNP02
| null |
DB18885
| null |
Bexicaserin
|
2035818-24-5
|
R8XR1D6SCB
|
(7R)-N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro[1,4]diazepino[6,7,1-hi]indole-8-carboxamide | Bexicaserin
|
KGOOOHQKLRUVSF-VIFPVBQESA-N
|
DB18886
| null |
Cadisegliatin
|
859525-02-3
|
98S8SH8UNF
|
[(2-{[cyclohexyl(trans-4-propoxycyclohexyl)carbamoyl]amino}-1,3-thiazol-5-yl)sulfanyl]acetic acid | 2-((2-(3-cyclohexyl-3-((1r,4r)-4-propoxycyclohexyl)ureido)thiazol-5-yl)thio)acetic acid | Acetic acid, 2-[[2-[[[cyclohexyl(trans-4-propoxycyclohexyl)amino]carbonyl]amino]-5-thiazolyl]thio]-
|
HPGJSAAUJGAMLV-QAQDUYKDSA-N
|
DB18887
| null |
Cagrilintide
|
1415456-99-3
|
AO43BIF1U8
|
Cagrilintide | CagriSema component Cagrilintide | L-Prolinamide, N-(19-carboxy-1-oxononadecyl)-L-γ-glutamyl-L-lysyl-L-cysteinyl-L-asparaginyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-alanyl-L-threonyl-L-glutaminyl-L-arginyl-L-leucyl-L-alanyl-L-α-glutamyl-L-phenylalanyl-L-leucyl-L-arginyl-L-histidyl
| null |
DB18888
| null |
Camonsertib
|
2417489-10-0
|
S1Z7Y5G56T
|
1R,3r,5S)-3-{6-[(3R)-3-methylmorpholin-4-yl]-1-(1Hpyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl}-8-oxabicyclo[3.2.1]octan-3-ol | 8-Oxabicyclo[3.2.1]octan-3-ol, 3-[6-[(3R)-3-methyl-4-morpholinyl]-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-, (3-endo)- | Camonsertib
|
YIHHYCIYAIVQKX-MBIULKOWSA-N
|
DB18889
| null |
Dazostinag
|
2553413-86-6
|
W4RT71M1YD
|
7-Deazainosine, [P(R)]-2′-deoxy-2′-fluoro-5′-O-[(R)-hydroxymercaptophosphinyl]-P-thioadenylyl-(3′→5′)-7-fluoro-, cyclic (2′→5′)-nucleotide | Dazostinag
|
SIIGKCBSQKWSLM-RNPBXGGWSA-N
|
DB18890
| null |
Depulfavirine
|
867365-76-2
|
ZP6H7RDZ5Q
|
2-[4-Bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl]-N-(2-chloro-4-sulfamoylphenyl)acetamide | Benzeneacetamide, N-[4-(aminosulfonyl)-2-chlorophenyl]-4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluoro- | Depulfavirine
|
SBUUICLVCQQMFP-UHFFFAOYSA-N
|
DB18891
| null |
Venanprubart
|
2635407-50-8
|
9A1RH2QLX2
|
Venanprubart
| null |
DB18892
| null |
Zigakibart
|
2642175-46-8
|
WM18Z62RTI
|
Zigakibart
| null |
DB18893
| null |
Volrustomig
|
2407760-40-9
|
K96EGJ218N
|
Volrustomig
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.